Texas Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Texas Technology Digest.

Press releases published on September 14, 2026

Star SEO Agency Launches SEO Services to Help U.S. Businesses Turn Search Visibility Into Customers
Sky Eye Network Member OmegaSkies Aerial Services Expands Central Texas Operations Into Commercial Construction Sector
New AI-Supported Gas Plume Colorization Feature for Flir OGI Cameras
ER/Studio 21.1 Expands Data Models Into Semantic Layers for AI and Analytics
BlueCloudX® Launches New Website, Designed to Simplify the Global Healthcare and Clinical Research Experience
Dispel Launches Community Power & Water Program at APPA Cybersecurity & Technology Summit
Questor Announces Resignation of Chief Financial Officer
Ascendis Announces Planned $400 Million Share Repurchase Program
Ascendis to Regain Rights to TransCon® Technology in Metabolic and Cardiovascular Diseases
What a Pharmacy Software Conversion Involves, From Data Migration to 90 Days of Support
Mike Tomlin to Keynote NC Central Basketball Tip-Off Banquet in First Fall Away From the Sideline
Curium™ announces FDA approval of BEXLUTRY lutetium Lu 177 dotatate injection for adults with SSTR-positive GEP-NETs
As Lithium Battery Markets Scale, Americase Experts to Address Safety and Compliance Challenges at LithiumSAFE 2026
NowSecure Finds 1 in 4 Mobile Apps May Expose Functionality to AI Agents Ahead of iOS 27
Filmore Brings Construction Equipment Demand Into Microsoft Teams
Veea Inc. and NovaGen announce potential merger to launch an Edge AI-Powered Global Health Platform
Robin van Poelje to Retire as CEO of Topicus.com Inc. on October 1, 2026; Board Names Ramon Zanders as his Successor
ShippingLabel.co Reports on 2026 Peak Schedules as First UPS and FedEx Domestic Demand Surcharges Start Sept. 27 and 28
Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study
Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Texas Technology Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.